Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
about
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene.An improved method for culturing patient-derived colorectal cancer spheroids.Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.
P2860
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@en
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@nl
type
label
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@en
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@nl
prefLabel
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@en
Significance of FGF9 gene in r ...... istant to anti-EGFR therapies.
@nl
P2093
P2860
P356
P1476
Significance of FGF9 gene in r ...... sistant to anti-EGFR therapies
@en
P2093
Akihiko Ito
Azusa Yoneshige
Hidetoshi Hayashi
Kazuhiko Nakagawa
Kazuko Sakai
Kazuto Nishio
Masato Terashima
Narikazu Boku
Saeko Naruki
P2860
P304
P356
10.1002/MC.22476
P577
2016-02-24T00:00:00Z